ArticleNeuro-oncology advances

A phase 0 clinical trial to evaluate the neuropharmacological profile of posaconazole for glioblastoma.

Alireza Mansouri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.